Search

everythinglearnresearchcommunity

for

Search:↓

More PDCD4 is linked to obesity, insulin problems, and cell death in ovaries for those with polycystic ovary syndrome.

A compound made by Pfizer can potentially stimulate hair growth and reduce oil production, making it a good candidate for topical use.

Drugs that block DHT production can effectively treat enlarged prostate and improve urinary issues with some sexual side effects.

The hydrogel with Finasteride provides controlled, sustained drug release and improved bioavailability.

PP405 may help hair growth by activating hair follicle stem cells.

Zinc sulfide cellulose scaffolds can reduce scarring and promote hair growth.

DA-9401 can protect against finasteride-induced reproductive damage in rats.

Oral paclitaxel plus encequidar improved tumor response and caused less neuropathy but more serious infections than intravenous paclitaxel.

Cepharanthine analogues, especially tetrandrine, show potential for treating COVID-19.

Finasteride may help treat BPH by affecting certain biological markers.

The MPA-ISO cocrystal improved solubility and dissolution rate, while the others did not.

Finasteride's molecular properties and active sites were identified using computational methods.

The research shows that hydrogen bonds greatly affect the crystal structure of a Finasteride derivative.

Dutasteride effectively treats enlarged prostate with manageable side effects.

Flibanserin may help improve sexual symptoms in various conditions beyond its approved use.

The MAPK/ERK pathway is crucial in controlling cell growth and death in finasteride-induced hypospadias.

Finasteride treats enlarged prostate, shrinks it, improves urination, but may cause sexual dysfunction and isn't for women or children.

Finasteride and baicalin in phospholipid vesicles effectively promote hair growth and increase follicle count.

The nano-carrier makes etoposide safer and more effective against lung cancer.

New nonsteroidal molecules can potentially increase dihydrotestosterone in neurons by blocking certain enzymes, without affecting prostate and seminal vesicle weight.

Finasteride reduces some inflammation in BPH but not all.

5α-reductase inhibitors like finasteride and dutasteride effectively treat BPH by reducing DHT levels.

Finasteride tablets are stable and effective for treating benign prostatic hyperplasia.

Four new cases of gynecomastia (male breast enlargement) linked to finasteride (Propecia) have been found.

Alpha-difluoromethylornithine prevents cancer in mice but causes hair loss.

Finasteride may cause changes in dopamine-related genes, possibly leading to post-finasteride syndrome.

Two new compounds can block androgen receptor activity in different ways and may lead to new treatments for androgen-related diseases.

Blocking CYP17A1 enzyme may help improve certain brain function issues related to dopamine.

Dutasteride reduces DHT and improves BPH symptoms more effectively than finasteride.

Breast cancer treatments work better with AR activation, improving results and reducing side effects.